Search

Your search keyword '"El Helali N"' showing total 33 results

Search Constraints

Start Over You searched for: Author "El Helali N" Remove constraint Author: "El Helali N" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
33 results on '"El Helali N"'

Search Results

4. MISE EN OEUVRE D’UN SYSTÈMES DE SURVEILLANCE DU SPECTRE DANS LA GAMME HAUTE FRÉQUENCE DANS LES PAYS EN DÉVELOPPEMENT AYANT DES TERRITOIRES RELATIVEMENT PETITS

8. Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium

11. French Intensive Care Society, International congress - Réanimation 2016

13. Intrapartum GBS screening and antibiotic prophylaxis : a European consensus conference

14. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference.

15. Comparaison de l’activité résiduelle de la moxifloxacine à celle de la lévofloxacine dans un modèle murin d’infection à Mycobacterium tuberculosisrésistant aux fluoroquinolones

16. French Intensive Care Society, International congress – Réanimation 2016

17. Levofloxacin activity at increasing doses in a murine model of fluoroquinolone-susceptible and -resistant tuberculosis.

18. Simultaneous determination of oxacillin and cloxacillin in plasma and CSF using turbulent flow liquid chromatography coupled to high-resolution mass spectrometry: Application in therapeutic drug monitoring.

19. What to Do with the New Antibiotics?

20. Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment.

21. The Coris BioConcept COVID 19 Ag Respi-Strip, a field experience feedback.

22. CSF concentration of cefotaxime in adult patients with pneumococcal meningitis: a multicentre retrospective study.

23. How to optimize administration of cefoxitin for the treatment of extended spectrum producing Enterobacteriaceae-related infection?

24. Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France.

25. A rapid, automatic and accurate assay for quantifying temocillin in human serum and CSF using turbulent flow liquid chromatography coupled to high-resolution mass spectrometry. Clinical application.

26. Risk Factors for Infant Colonization by Hypervirulent CC17 Group B Streptococcus: Toward the Understanding of Late-onset Disease.

27. PHARMECMO: Therapeutic drug monitoring and adequacy of current dosing regimens of antibiotics in patients on Extracorporeal Life Support.

28. Continuous infusion of ceftolozane/tazobactam is associated with a higher probability of target attainment in patients infected with Pseudomonas aeruginosa.

29. Point-of-Care Intrapartum Group B Streptococcus Molecular Screening: Effectiveness and Costs.

30. Variable spectrum of disease and risk factors of peripartum Clostridium difficile infection: report of 14 cases from French hospitals and literature review.

31. Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects.

32. Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?

33. Absence of obvious link between supra-therapeutic serum levels of β lactams and clinical toxicity in ICU patients with acute renal failure treated with intermittent hemodialysis.

Catalog

Books, media, physical & digital resources